Dialyse und Hypertonie

M. van der Giet; W. Zidek

doi:10.1055/s-2006-956257

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2006; 131(46): 2605-2609
DOI: 10.1055/s-2006-956257

Übersicht | Review article

Hypertensiologie, Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Dialyse und Hypertonie

Haemodialysis and hypertensionM. van der Giet¹ , W. Zidek¹

¹Medizinische Klinik IV - Nephrologie, Charite - Campus Benjamin Franklin, Berlin

Abstract

Schlüsselwörter

Hämodialyse - Hypertonie - Therapie

Key words

hemodialysis - hypertension - therapy

Volltext

Referenzen

Literatur

1 Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement . Ann Intern Med. 1994; 121 62-70
2 Agarwal R. Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis. Hemodialysis Int. 2004; 8 208
3 Agarwal R. Hypertension and survival in chronic hemodialysis patients - past lessons and future opportunities. Kidney Int. 2005; 67 1-13
4 Agarwal R. Hypertension in chronic kidney disease and dialysis: pathophysiology and management. Cardiol Clin. 2005; 23 237-248
5 Agarwal R. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring. Curr Opin Nephrol Hypertens. 2006; 15 309-313
6 Agarwal R, Nissenson A R, Batlle D, Coyne D W, Trout J R, Warnock D G. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115 291-297
7 Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel J P. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002; 136 438-448
8 Charra B, Calemard E, Ruffet M, Chazot C, Terrat J C, Vanel T. et al . Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41 1286-1291
9 Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E. et al . The Janus-faced aspect of ‘dry weight’. Nephrol Dial Transplant. 1999; 14 121-124
10 de Paula F M, Peixoto A J, Pinto L V, Dorigo D, Patricio P J, Santos S F. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int. 2004; 66 1232-1238
11 Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis?. Kidney Int Suppl. 1996; 55 S173-174
12 Foley R N, Parfrey P S. Cardiovascular disease and mortality in ESRD. J Nephrol. 1998; 11 239-245
13 Himmelfarb J, Stenvinkel P, Ikizler T A, Hakim R M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62 1524-1538
14 Jaeger J Q, Mehta R L. Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol. 1999; 10 392-403
15 Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?. Semin Dial. 2005; 18 365-369
16 Kalantar-Zadeh K, Block G, Humphreys M H, Kopple J D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63 793-808
17 Kalantar-Zadeh K, Kilpatrick R D, McAllister C J, Greenland S, Kopple J D. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension. 2005; 45 811-817
18 Kestenbaum B, Gillen D L, Sherrard D J, Seliger S, Ball A, Stehman-Breen C. Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int. 2002; 61 2157-2164
19 Klassen P S, Lowrie E G, Reddan D N, DeLong E R, Coladonato J A, Szczech L A. et al . Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. Jama. 2002; 287 1548-1555
20 Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000; 58 2147-2154
21 Salem M M. Hypertension in the haemodialysis population: any relationship to 2-years survival?. Nephrol Dial Transplant. 1999; 14 125-128
22 Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N. Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients. Am J Kidney Dis. 2005; 45 112-118
23 Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y. et al . Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis. 1995; 25 405-412
24 Tozawa M, Iseki K, Fukiyama K. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi. 1996; 38 129-135
25 Zager P G, Nikolic J, Brown R H, Campbell M A, Hunt W C, Peterson D. et al . „U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc Kidney Int. 1998; 54 561-569
26 Zazgornik J, Biesenbach G, Janko O, Gross C, Mair R, Brucke P. et al . Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Am J Hypertens. 1998; 11 1364-1370

Prof. Dr. med. Markus van der Giet

Charite - Campus Benjamin Franklin, Med. Klinik IV - Nephrologie

Hindenburgdamm 30

12200 Berlin

Telefon: +49/30/84453021

Fax: +49/30/84453338

eMail: markus.vandergiet@charite.de